Skip to content

Zanganeh Mahkam

Reporting owner on Forms 3, 4 and 5, CIK 1507650.

Zanganeh Mahkam reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-20.

Issuers

IssuerRoles in the latest filingFilingsLast filed
SMMT · Summit Therapeutics Inc.CIK 1599298director, officer (Co-Chief Executive Officer), 10% owner22026-11-20

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
SMMT · Summit Therapeutics Inc.Common Stock2026-11-20M exercised+300,000$1.06831,000Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 25,824,474Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 76,680Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 10,199,776Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 573,883,879Form 4
SMMT · Summit Therapeutics Inc.Stock Option (right to buy), derivative2026-11-20M exercised-300,000$0500,000Form 4
SMMT · Summit Therapeutics Inc.Common Stock2026-11-16M exercised+500,000$1.06531,000Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 25,824,474Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 76,680Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 10,199,776Form 4
SMMT · Summit Therapeutics Inc.Common Stock, holding 573,883,879Form 4
SMMT · Summit Therapeutics Inc.Stock Option (right to buy), derivative2026-11-16M exercised-500,000$0800,000Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001507650-26-000011 Summit Therapeutics Inc.2026-11-20
Form 4 0001507650-26-000009 Summit Therapeutics Inc.2026-11-16